Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a...
Sanofi has announced the inauguration its new modular vaccine and biomedicine pr...
Gilead Sciences has partnered with Genesis Therapeutics to discover and develop ...
As the approval date for Bristol Myers Squibb’s schizophrenia drug KarXT looms, ...
The FDA has granted breakthrough therapy designation to Neuraptive Therapeutics’...
Johnson & Johnson has announced that the US FDA has approved TREMFYA for the tre...
EASD 2024 participants are looking for the hottest efficacy data to make predict...
The IBA-SCK CEN joint venture secured funds to increase production of the radioi...
Children aged 6-12 years achieved a 5.8% reduction in BMI with Novo Nordisk's Sa...
NanoSyrinx has secured £10m ($13m) aimed at advancing its technology for targete...
The US FDA has granted breakthrough therapy designation to Arrowhead Pharmaceuti...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
Sildenafil citrate is under clinical development by XOMA Royalty and currently i...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
